Palazestrant
OP-1250-302
Phase 3 small_molecule active
Quick answer
Palazestrant for Breast Cancer is a Phase 3 program (small_molecule) at Olema Pharmaceuticals with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Olema Pharmaceuticals
- Indication
- Breast Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active